A patient with Marfan's syndrome and neurofibromatosis type 1 with polyneuropathy

European Journal of Neurology

Volumn 11, Issue 9, 2004, Pages 641-644

  Hartlapp, I ^a   Buhring U ^a   Dichgans, J ^a   Isenmann, S ^a,b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

MRI; Neurofibroma; Neuropathy; NF 1; Pain; Schwannoma

Indexed keywords

AMITRIPTYLINE; CARBAMAZEPINE; CELECOXIB; DICLOFENAC; DIPYRONE; ESTROGEN; FLUPIRTINE; GABAPENTIN; PRIMIDONE; TILIDINE; TRAMADOL;

ADULT; ANAMNESIS; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CASE REPORT; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; ESTROGEN THERAPY; FEMALE; GENE MUTATION; GENETIC DISORDER; GROWTH DISORDER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LABORATORY TEST; LOW BACK PAIN; MARFAN SYNDROME; NERVE CONDUCTION; NEURILEMOMA; NEUROFIBROMA; NEUROFIBROMATOSIS; NEUROLOGIC EXAMINATION; PHYSICAL EXAMINATION; POLYNEUROPATHY; PRIORITY JOURNAL; RADIODIAGNOSIS; TUMOR GROWTH;

EID: 4644220307     PISSN: 13515101     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2004.00913.x     Document Type: Article

References (12)

1. Baser ME, Friedman JM, Wallace AJ, Ramsden RT, Joe H, Evans DG (2002). Evaluation of clinical diagnostic criteria for neurofibromatosis 2. Neurology 59:1759-1765.
2. Bosch EP, Murphy MJ, Cancilla PA (1981). Peripheral neurofibromatosis and peroneal muscular atrophy. Neurology 31:1408-1414.
3. Copeland T, Tiwary CM, Coker S (1986). Coexistence of neurofibromatosis and Marfan's syndrome. South Med J 79:489-492.
4. De Paepe A, Devereux RB, Dietz HC, Hennekam RC, Pyeritz RE (1996). Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet 62:417-426.
5. Ferner RE, O'Doherty MJ (2002). Neurofibroma and schwannoma. Curr Opin Neurol 15:679-684.
6. Kleihues P, Cavanee WK (1997). Tumours of the Nervous System. International Agency for the Research on Cancer, Lyon.
7. Leramo OB, Fraser H, Morgan OS (1985). Sporadic concurrence of von Recklinghausen's neurofibromatosis and Marfan syndrome. West Indian Med J 34:131-133.
8. MacCollin M, Woodfin W, Kronn D, Short MP (1996). Schwannomatosis: a clinical and pathologic study. Neurology 46:1072-1079.
9. NIoHCD Conference (1988). Neurofibromatosis. Conference statement. Arch Neurol 45:575-578.
10. Packer RJ, Gutmann DH, Rubenstein A et al. (2002). Plexiform neurofibromas in NF1: toward biologic-based therapy. Neurology 58:1461-1470.
11. Robinson PN, Booms P, Katzke S et al. (2002). Mutations of FBN1 and genotype-phenotype correlations in Marfan syndrome and related fibrillinopathies. Hum Mutat 20:153-161.
12. Witwicki T, Kutrzebski A (1974). Marfan syndrome and neurofibromatosis in the same patient. Wiad Lek 27:561-562.